首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS) I. Design of SCRS and its release controlling factor
【24h】

Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS) I. Design of SCRS and its release controlling factor

机译:口服控释制剂,PVA溶胀控释系统(SCRS)的开发I. SCRS的设计及其释放控制因素

获取原文
获取原文并翻译 | 示例
           

摘要

Polyvinyl alcohol (PVA) is hydrophilic and swells easily by absorbing water. Some grades of PVA, whose degree of hydrolysis is 96.0 and 97.5 mol%, showed volume expansion of 500% by swelling at 37 degrees C. This expansion was inhibited by swelling controlling agents, namely salts. Based on this unique property of PVA, a new type of controlled release system was developed. The release rate was controlled by the content of PVA and a swelling controlling agent in the core tablet, and the composition and coating level of the film. Emedastine difumarate was incorporated into the system. At the initial stage of drug release, the rate of release was determined by the permeation through the membrane - a mixture of ethylcellulose and hydroxypropyl methylcellulose. After the membrane burst by the swelling of PVA, the release rate was controlled by the PVA matrix. Release patterns of zero-order, two phase zero-order, and rapid release after lag-time were obtained with this system. (C) 2000 Elsevier Science B.V. All rights reserved. [References: 12]
机译:聚乙烯醇(PVA)是亲水性的,吸收水后很容易膨胀。某些等级的PVA,其水解度为96.0和97.5 mol%,通过在37摄氏度下溶胀表现出500%的体积膨胀。这种膨胀被溶胀控制剂(盐)抑制。基于PVA的这一独特特性,开发了一种新型的控释系统。释放速率由芯片中PVA和溶胀控制剂的含量以及膜的组成和包衣水平控制。富马酸艾美他汀被并入系统。在药物释放的初始阶段,释放速率由乙基膜和羟丙基甲基纤维素的混合物透过膜的渗透率决定。在膜因PVA溶胀而破裂后,释放速率由PVA基质控制。该系统获得了零阶,两相零阶和滞后后快速释放的释放模式。 (C)2000 Elsevier Science B.V.保留所有权利。 [参考:12]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号